| # | Drug | Count |
|---|---|---|
| 0 | FOLIC ACID | 52 |
| 1 | FLUOXETINE HYDROCHLORIDE | 41 |
| 2 | LAMOTRIGINE | 39 |
| 3 | SERTRALINE HYDROCHLORIDE | 33 |
| 4 | LAMOTIRIGINE | 32 |
| 5 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 32 |
| 6 | LAMOTRIGINE EXTENDED-RELEASE | 32 |
| 7 | SERTRALINE | 28 |
| 8 | DARUNAVIR ETHANOLATE AND COBICISTAT | 26 |
| 9 | LAMIVUDINE | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALKA-SELTZER GOLD | 1 | 0.0192 |
| 1 | ABACAVIR AND LAMIVUDINE | 3 | 0.0150 |
| 2 | DARUNAVIR ETHANOLATE AND COBICISTAT | 26 | 0.0148 |
| 3 | BUPRENORPHINE HCL | 4 | 0.0046 |
| 4 | DARUNAVIR 600 MG | 21 | 0.0034 |
| 5 | NELFINAVIR MESYLATE | 5 | 0.0024 |
| 6 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| 7 | ABACAVIR SULFATE | 20 | 0.0021 |
| 8 | DARUNAVIR | 22 | 0.0015 |
| 9 | RALTEGRAVIR | 7 | 0.0013 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 34 | 0.0008 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 40 | 0.0007 |
| 2 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 5 | 0.0006 |
| 3 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 30 | 0.0006 |
| 4 | Progesterone [EPC] | 11 | 0.0005 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 4 | 0.0004 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 37 | 0.0003 |
| 7 | Oxytocic [EPC] | 1 | 0.0003 |
| 8 | Typical Antipsychotic [EPC] | 5 | 0.0002 |
| 9 | Cholinergic Nicotinic Agonist [EPC] | 12 | 0.0002 |